SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Cohen Solal A.)
 

Sökning: WFRF:(Cohen Solal A.) > (2005-2009) > Practical recommend...

Practical recommendations for the use of ACE inhibitors, beta-blockers, aldosterone antagonists and angiotensin receptor blockers in heart failure: Putting guidelines into practice

McMurray, J (författare)
Cohen-Solal, A (författare)
Dietz, R (författare)
visa fler...
Eichhorn, E (författare)
Erhardt, Leif RW (författare)
Lund University,Lunds universitet,Internmedicin - epidemiologi,Forskargrupper vid Lunds universitet,Internal Medicine - Epidemiology,Lund University Research Groups
Hobbs, FDR (författare)
Krum, H (författare)
Maggioni, A (författare)
McKelvie, RS (författare)
Pina, IL (författare)
Soler-Soler, J (författare)
Swedberg, Karl, 1944 (författare)
Gothenburg University,Göteborgs universitet,Hjärt-kärlinstitutionen,Cardiovascular Institute
visa färre...
 (creator_code:org_t)
2005-08-07
2005
Engelska.
Ingår i: European Journal of Heart Failure. - : Wiley. - 1879-0844 .- 1388-9842. ; 7:5, s. 710-721
  • Tidskriftsartikel (refereegranskat)
Abstract Ämnesord
Stäng  
  • Surveys of prescribing patterns in both hospitals and primary care have usually shown delays in translating the evidence from clinical trials of pharmacological agents into clinical practice, thereby denying patients with heart failure (HF) the benefits of drug treatments proven to improve well-being and prolong life. This may be due to unfamiliarity with the evidence-base for these therapies, the clinical guidelines recommending the use of these treatments or both, as well as concerns regarding adverse events. ACE inhibitors have long been the cornerstone of therapy for systolic HF irrespective of aetiology. Recent trials have now shown that treatment with beta-blockers, aldosterone antagonists and angiotensin receptor blockers also leads to substantial improvements in outcome. In order to accelerate the safe uptake of these treatments and to ensure that all eligible patients receive the most appropriate medications, a clear and concise set of clinical recommendations has been prepared by a group of clinicians with practical expertise in the management of HE The objective of these recommendations is to provide practical guidance for non-specialists, in order to increase the use of evidenced based therapy for HF. These practical recommendations are meant to serve as a supplement to, rather than replacement of, existing HF guidelines.

Ämnesord

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Kardiologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cardiac and Cardiovascular Systems (hsv//eng)

Nyckelord

beta-blockers
clinical recommendations
digoxin
eplerenone
heart
failure
hydralazine
isosorbide dinitrate
pharmacology
treatment
spironolactone
angiotensin receptor blockers
ACE inhibitors
aldosterone antagonists
converting-enzyme-inhibitors
ventricular systolic dysfunction
randomized intervention trial
quality-of-care
elderly-patients
cardiac-insufficiency
medical-treatment
general-practice
national-survey

Publikations- och innehållstyp

art (ämneskategori)
ref (ämneskategori)

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy